Harbor Capital Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Harbor Capital Advisors's ASTH Position: Q2 2026 in Review
Harbor Capital Advisors increased its Astrana Health (ASTH) stake by 1.3% in Q2 2026, buying an estimated $144 and bringing the position to 321 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #914.
Harbor Capital Advisors first reported a position in ASTH in Q3 2025 and has held it in 4 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Harbor Capital Advisors held 321 shares of Astrana Health worth $15K as of Q2 2026.
- Harbor Capital Advisors bought 4 Astrana Health shares in Q2 2026, an estimated $144.
- Astrana Health made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #914 holding.
- Harbor Capital Advisors first reported a position in Astrana Health in Q3 2025 and has held it in 4 quarters since.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.